AlgoMedica's PixelShine will be integrated into InferVision's InferRead CT pneumonia software. The companies aim to improve the ability of the Infervision AI algorithms to analyze ultralow-dose lung CT imaging by reducing noise inherent in these studies.
The collaboration is part of a broader effort to improve the effectiveness of ultralow-dose CT in the detection of COVID-19 in patients. Both companies are partners in a consortium that is seeking 2 million euros (about $2.16 million) in funding from the European Union to establish
a standardized and quantitative procedure to enable improved, faster diagnosis of COVID-19 using AI and ultralow-dose CT.
The combined software is in the process of being installed at hospitals in several countries in Europe, including Germany and Italy.
Copyright © 2020 AuntMinnie.com